Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Pathfinder Publication

20 Nov 2009 09:59

RNS Number : 8391C
F&C Private Equity Trust PLC
20 November 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OF AMERICA or any jurisdiction in which the same could be unlawful OR TO US PERSONS. the information contained herein does not constitute an offer of securities for sale including in australiacanadajapan or the united states of america

THIS ANNOUNCEMENT IS AN ADVERTISMENT AND NOT A PROSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS to be PUBLISHED BY F&C private equity trust plc and F&C PRIVATE EQUITY ZEROS PLC IN CONNECTION WITH THE PROPOSED PLACING

20 November 2009

F&C Private Equity Trust plc(THE "COMPANY")

PATHFINDER PUBLICATION 

F&C Private Equity Trust plc announces that its new wholly-owned subsidiary, F&C Private Equity Zeros plc ("F&C PEZ") has today published its pathfinder prospectus (the "Pathfinder") in connection with the institutional placing (the "Placing") to raise gross proceeds of up to £30 million through the issue of five-year term zero dividend preference shares ("ZDP Shares"with a redemption yield of 8.0 per cent. per annum as announced on 19 October 2009.

The Placing and the Pathfinder are only being directed at and made available to certain limited institutional investors. Neither the Pathfinder nor the Placing are being made available to the public.

Enquiries

Hamish Mair, Investment Manager

F&C Asset Management PLC

T: 0131 718 1184 

Alastair Moreton, Placing Agent and Broker

Arbuthnot Securities Limited

T: 020 7012 2000

Sue Inglis, Sponsor and Financial Adviser

Intelli Corporate Finance Limited

T: 020 7050 6779

Prospectus

Copies of the prospectus can be obtained, once available, subject to all applicable law, at no cost from the registered office of the Company, at 80 George Street, Edinburgh EH2 3BU and at the UK Listing Authority's document viewing facility at 25 The North Colonnade, Canary Wharf, London E14 5HS.

Important Notes

This announcement has been issued by and is the sole responsibility of the Company. 

Intelli Corporate Finance Limited, which is authorised and regulated in the United Kingdom for the conduct of investment business by the Financial Services Authority, is acting exclusively as financial adviser to the Company and F&C PEZ and no-one else in connection with the matters referred to in this announcement and will not regard any other person as its client in relation to the matters referred to in this announcement and will not be responsible to anyone other than the Company and F&C PEZ for providing the protections afforded to clients of Intelli Corporate Finance Limited or for providing advice in relation to the matters referred to in this announcement.

Arbuthnot Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting solely for the Company and F&C PEZ and will not regard any other person as its client in relation to the Placing and will not be responsible to anyone other than the Company and F&C PEZ for providing the protections afforded to clients of Arbuthnot Securities Limited or for providing advice in relation to the Placing or any other transaction or matter referred to in this announcement.

This announcement and the Pathfinder are for information purposes only and do not constitute an invitation to subscribe for or otherwise acquire or dispose of any securities of the Company or F&C PEZ in any jurisdiction. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or the Pathfinder or their accuracy or completeness. This announcement and the Pathfinder do not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investments nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

Acquiring ZDP Shares may expose an investor to a risk of losing all of the amount invested.  The value of shares (including zero dividend preference shares) can go down as well as up. Past performance is not a guide to future performance. This announcement does not constitute a recommendation concerning the Placing.  Persons considering investing in the ZDP Shares should consult an authorised person specialising in advising on zero dividend preference shares. Potential investors should consult a professional advisor as to the suitability of the Placing for the person concerned.

The Placing and Pathfinder will only be addressed to and directed at persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 21(1)(e) of the Prospectus Directive (Directive 2003/71/EC) ("Qualified Investors"). In addition, in the United Kingdom, this document is being distributed only to and is directed only at Qualified Investors (i) who are persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who are high net worth entities falling within Article 49 of the Order, and (iii) other persons to whom it may otherwise lawfully be communicated (all such persons together referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on the Pathfinder of any of its contents. Any investment or investment activity to which this document relates is available only to (a) in the United Kingdom, relevant persons, and (b) in any member state of the European Economic Area other than the United Kingdom, Qualified Investors, and will be engaged in only with such persons.

Allocations in the Placing will only be made available to institutional investors in the UK and elsewhere outside the US in reliance on Regulation S under the US Securities Act of 1933, as amended.

This announcement, the Pathfinder (or any part of it) and the information contained in this announcement and in the Pathfinder are not for publication, distribution, reproduction or release in or into, directly or indirectly, the United States of America. These materials do not contain or constitute an offer of securities for sale in the United States The ZDP Shares have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration under that Act or an available exemption from it.  Neither the Company nor F&C PEZ intends to register the securities or conduct a public offering in the United States. Neither the Company nor F&C PEZ will be registered under the US Investment Company Act of 1940, as amended, and investors will not be entitled to the benefits of that Act.

No securities issued or to be issued by the Company or F&C PEZ have been or will be registered under the applicable securities laws of AustraliaCanada or Japan and, subject to certain exceptions, such securities may not be offered or sold in AustraliaCanada or Japan.

The Placing and the distribution of this announcement and the Pathfinder in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to this announcement or the Pathfinder comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRCKKKPCBDKQDB
Date   Source Headline
20th May 20202:54 pmRNSResult of AGM
19th May 20209:38 amRNSHolding(s) in Company
20th Apr 20203:43 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSFinal Results announcement
9th Apr 20201:47 pmRNSResults Announcement – Update
8th Apr 202010:22 amRNSHolding(s) in Company
2nd Apr 20204:59 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSDividend Declaration
22nd Nov 20197:00 amRNSThird Quarter Results and Dividend Announcement
23rd Oct 201910:20 amRNSHolding(s) in Company
23rd Oct 201910:19 amRNSHolding(s) in Company
23rd Aug 20197:00 amRNSHalf-year Report
24th Jun 20197:00 amRNSFinancing
24th May 20199:11 amRNSResult of AGM
23rd May 201911:41 amRNSFirst Quarter Results & Dividend Announcement
16th Apr 20193:46 pmRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSAnnual Financial Report
22nd Mar 20194:02 pmRNSHolding(s) in Company
22nd Mar 20197:00 amRNSAnnual Financial Report
23rd Nov 20187:00 amRNSThird Quarter Results and Dividend Announcement
9th Nov 20182:48 pmRNSChange of Name
9th Oct 20184:25 pmRNSDirector/PDMR Shareholding
6th Sep 20189:49 amRNSPartial exit of significant holding
24th Aug 20187:00 amRNSHalf-year Report
19th Jun 201812:51 pmRNSHolding(s) in Company
24th May 20184:09 pmRNSResult of AGM
24th May 201811:51 amRNS1st Quarter Results
9th Apr 20188:25 amRNSAnnual Financial Report
23rd Mar 20187:00 amRNSAnnual Financial Report
24th Nov 20177:00 amRNSThird Quarter Results and Dividend Announcement
7th Nov 201711:53 amRNSHolding(s) in Company
3rd Nov 20174:08 pmRNSHolding(s) in Company
30th Aug 20173:45 pmRNSDirector/PDMR Shareholding
25th Aug 20177:00 amRNSHalf-year Report
25th May 20173:58 pmRNSAGM Statement
25th May 201710:49 amRNS1st Quarter Results
21st Apr 20172:44 pmRNSHolding(s) in Company
19th Apr 20176:12 pmRNSDirector/PDMR Shareholding
11th Apr 20178:49 amRNSHolding(s) in Company
10th Apr 20177:00 amRNSAnnual Financial Report
28th Mar 20173:45 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSAnnual Financial Report
24th Nov 20167:00 amRNSThird Quarter Results
30th Aug 201611:34 amRNSDirector/PDMR Shareholding
26th Aug 20167:01 amRNSHalf-year Report
20th Jun 20167:01 amRNSIssue of Equity
25th May 20163:18 pmRNSAGM Statement
25th May 201611:58 amRNS1st Quarter Results
15th Apr 20161:20 pmRNSDirector/PDMR Shareholding
8th Apr 20167:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.